首页|两种肿瘤病儿肿瘤异常蛋白的检测及临床意义

两种肿瘤病儿肿瘤异常蛋白的检测及临床意义

扫码查看
目的 探讨肿瘤异常蛋白(TAP)在急性淋巴细胞白血病(ALL)及神经母细胞瘤(NB)病儿中的表达及与化疗效果的相关性,为病儿诊断及疗效评估、肿瘤复发监测提供参考.方法 收集93例肿瘤病儿,其中ALL病儿67例,NB病儿26例.病儿治疗前均制备外周血涂片测TAP,ALL病儿检测血清乳酸脱氢酶(LDH),NB病儿检测神经元特异性烯醇化酶(NSE).治疗完全缓解后,ALL病儿检测血清LDH及行骨髓穿刺检测微小残留病灶(MRD),NB病儿检测血清NSE.结果 ALL新发、缓解病儿TAP阳性率分别为62.50% (20/32)和37.14%(13/35),新发病儿TAP阳性率明显高于缓解病儿(x2=4.30,P<0.05).ALL新发、缓解病儿TAP阳性率与血清LDH检测异常率比较差异均无显著性(P>0.05).临床完全缓解ALL病儿中MRD<10-4/L组的TAP阳性率低于MRD≥10-4/L组(P=0.04).NB新发、缓解病儿TAP阳性率分别为81.25%(13/16)和30.00%(3/10),新发病儿TAP阳性率明显高于缓解病儿(P=0.02).NB新发、缓解病儿TAP阳性率与血清NSE检测异常率比较差异均无显著性(P>0.05).Ⅲ期及Ⅳ期新发NB病儿TAP阳性率分别为75.00%(6/8)和87.50%(7/8),二者比较差异无显著性(P>0.05).结论 TAP检测在ALL及NB中均具有较高的灵敏度,因操作简便、创伤小,可用于这两类常见儿童肿瘤的筛查.TAP检测与肿瘤负荷具有较高的一致性,可用于治疗缓解后复发监测.
DETECTION OF TUMOR ABNORMAL PROTEIN AND ITS CLINICAL SIGNIFICANCE IN CHILDREN WITH TUMOR
Objective To investigate the expression of tumor abnormal protein (TAP) and its correlation with the chemotherapeutic effect in children with acute lymphoblastic leukemia (ALL) or neuroblastoma (NB),and to provide a reference for the diagnosis,the evaluation of treatment effect,and monitoring of tumor recurrence in children with the two tumors.Methods A total of 93 children with tumor were enrolled in this study,including 67 ALL children and 26 NB children.Before treatment,TAP was detected by peripheral blood smear review in all patients;the serum level of lactate dehydrogenase (LDH) was measured in the sampled ALL children;the serum level of neuron-specific enolase (NSE) was measured in the sampled NB children.After complete remission,the serum level of LDH was measured and bone marrow biopsy was performed to detect minimal residual disease (MRD) in the sampled ALL children;the serum level of NSE was measured in the sampled NB children.Results The children with new-onset ALL had a significantly higher positive rate of TAP than the children with remission of ALL (62.50% (20/32) vs 37.14% (13/35);x2 =4.30,P<0.05).There were no significant differences in the positive rate of TAP and the abnormal rate of LDH level between the children with new onset ALL and the children with remission of ALL (P>0.06).For children with clinical complete remission of ALL,the positive rate of TAP in the MRD <10 4/L group was significantly lower than that in the MRD ≥10-4/L group (P=0.04).The children with new-onset NB had a significantly higher positive rate of TAP than the children with remission of NB (81.25% (13/16) vs 30.00% (3/10);P=0.02).There were no significant differences in the positive rate of TAP and the abnormal rate of NSE level between the children with new-onset NB and the children with remission of NB (P>0.05).For children with new-onset NB,the positive rates of TAP in stage Ⅲ and Ⅳ were 75% (6/8) and 87.50% (7/8),respectively,and there was no significant difference in the positive rate of TAP between the children with new-onset NB in the two stages (P>0.05).Conclusion TAP detection can be used as an indicator for screening out ALL and NB in children because of its high sensitivity,simple operation,and minimal invasion.The result of TAP detection is correlated with tumor burden,so it can be used for predicting recurrence after treatment.

leukemia, lymphoidneuroblastomatumor abnormal proteinsneoplasm,residuallactate dehydrogenasesphosphopyruvate hydratase

邴振、卢愿、曹永献、仲任、赵艳霞

展开 >

青岛市妇女儿童医院儿科,山东青岛266034

青岛大学附属医院血液儿科

青岛大学附属医院检验科

白血病,淋巴样 神经母细胞瘤 肿瘤异常蛋白 肿瘤,残余 乳酸脱氢酶类 磷酸丙酮酸水合酶

2017

齐鲁医学杂志
青岛大学医学院

齐鲁医学杂志

影响因子:0.609
ISSN:1008-0341
年,卷(期):2017.32(4)
  • 7